HLA-DQB1 rs9274496: Genetic Risk and Peanut Allergy

What each genotype means

Genomic Location and the HLA Class II Region

The single-nucleotide polymorphism rs9274496 resides within the major histocompatibility complex (MHC) on the short arm of chromosome 6 (6p21.32). This specific locus is mapped near the HLA-DQB1 gene, which encodes the beta chain of the heterodimeric human leukocyte antigen class II DQ molecule. The MHC is one of the most polymorphic and genetically dense regions of the human genome, characterized by extensive linkage disequilibrium where many nearby single-nucleotide variants are inherited together in conserved ancestral haplotypes. Because of this intricate architecture, non-coding and regulatory variants like rs9274496 often serve as surrogate tags for specific HLA alleles or functional regulatory elements that control the transcription and cell-surface expression of class II antigen-presenting molecules on antigen-presenting immune cells such as dendritic cells and B lymphocytes.

Biological Function of HLA-DQB1

HLA-DQ molecules are heterodimeric cell-surface glycoproteins made of an alpha chain and a beta chain. They function primarily on professional antigen-presenting cells, capturing peptides derived from extracellular proteins and presenting them to CD4+ helper T cells. This molecular presentation step is critical for immune self-tolerance and determining whether an environmental antigen is ignored or recognized as a threat. When an external protein—such as an allergen peptide from peanuts—is displayed with high binding affinity, it can activate allergen-specific T helper 2 (Th2) cells. This activation promotes class-switching in B cells to generate allergen-specific immunoglobulin E (IgE) antibodies. Genetic variation across the peptide-binding grooves of HLA-DQB1, or in regulatory variants modulating its expression, directly influences the repertoire of exogenous peptides presented to the immune system.

Evidence Strength and Peanut Allergy Risk

Genome-wide association studies (GWAS) and candidate gene analyses have repeatedly highlighted the HLA-DR and HLA-DQ genomic regions in IgE-mediated food allergies, specifically peanut hypersensitivity. Cohorts evaluating class II variation have identified significant statistical signals around rs9274496 and neighboring tagging variants, showing that specific risk alleles associate with higher odds of peanut sensitization. Mechanistic investigations suggest these associations are partly mediated through differential DNA methylation patterns and altered expression of HLA-DQB1 and HLA-DRB1 transcripts. However, the scientific evidence supporting rs9274496 as an independent, causative predictor is classified as limited. Food allergy susceptibility is inherently polygenic and displays complex ancestry-specific architecture. Variants identified in European ancestral cohorts often do not replicate with identical effect sizes in populations of African or East Asian descent.

Understanding What This Information Means for You

Carrying an effect allele at rs9274496 indicates a modest statistical variation in the likelihood of developing peanut allergy compared to population averages; it does not constitute a diagnosis or a guarantee of disease. Genetic testing cannot confirm an active food allergy, nor does possessing typical non-risk alleles ensure absolute protection against allergic sensitization. Clinical diagnosis of a food allergy requires an evaluation by an allergist, incorporating documented clinical reactions after ingestion, skin prick tests, and allergen-specific serum IgE measurements. No one should alter their dietary habits, eliminate peanut products from their household, or attempt oral peanut challenges based on recreational or direct-to-consumer genetic data alone. Readers suspecting allergic symptoms should seek comprehensive clinical evaluation from a qualified healthcare professional.

Frequently asked questions

Sources & further reading

Related variants in HLA-DQB1